ESMED small

Mr

Up tBackground. Globally, anemia, among people living with HIV/AIDS, is a major public health problem. It has a signifcant efect
on the progression of HIV/AIDS to advanced stages and there are a number of factors that ofen afect anemia. However, there is
little insight regarding factors afecting anemia among HIV/AIDS patients in developing countries, including Ethiopia. Objective.
Tis study aimed at investigating factors afecting anemia among people living with HIV/AIDS taking ART drug at Tikur Anbessa
Specialized Hospital, Addis Ababa, Ethiopia. Methods. A hospital based cross-sectional study design was used to assess factors
afecting anemia among people living with HIV/AIDS. Structured checklist was used to gather information from charts of patients
selected by simple random sampling method. We analyzed the data to identify factors associated with anemia among people with
HIV/AIDS using logistic regression models. Results. A total of 301 selected charts were reviewed. Te median age was 38 ± 10.38.
Te majority (62.5%) of the patients were taking ZDV-containing ART drug (ZDV/3TC/NVP). Te overall anemia prevalence was
34.6%, while about 5%, 15.6%, and 14% of the patients had severe, moderate, and mild prevalence of anemia, respectively. Factors
that were found to afect anemia among these patients include gender (OR = 2.26 [95% CI: 1.22, 4.16]), occupation (OR: 0.57 [95%CI:
0.35, 0.92]), WBC count (OR = 2.30 [95% CI: 1.29, 4.09]), platelet count (OR = 2.89 [95% CI: 0.99, 8.41]), nutritional status (OR
= 2.05 [95% CI: 0.69, 6.02]), and WHO clinical stage of HIV/AIDS (OR = 3.69 [95% CI: 1.86, 7.31]). Conclusions. About one in
three patients was found to be anemic. Intervention aimed at diagnosing and treating anemia among people living with HIV/AIDS
should be considered.o 350 words. No references allowed. Abstracts may be submitted at a later date.